Streamline Health Announces Appointment of Interim Chief Financial Officer
November 26 2008 - 4:05PM
PR Newswire (US)
CINCINNATI, Nov. 26 /PRNewswire-FirstCall/ -- Streamline Health
Solutions, Inc. (NASDAQ:STRM) today announced that its Board of
Directors has appointed Donald E. Vick, Jr., as the Company's
interim Chief Financial Officer pending the Board's selection of a
new permanent Chief Financial Officer. Mr. Vick may be considered
as a candidate for such position. Pending the selection of a
permanent Chief Financial Officer, Mr. Vick will also continue to
serve as the Company's Controller, Assistant Treasurer and
Assistant Secretary; positions he has held since February, 2002.
About Streamline Health Solutions, Inc. Streamline Health is a
leading supplier of workflow and document management tools,
applications and services that enable strategic business partners
and healthcare organizations to improve operational efficiencies
through business process optimization. The Company provides
integrated technology solutions for automating document-intensive
environments, including document workflow, document management,
e-forms, portal connectivity, optical character recognition (OCR),
and interoperability. Streamline Health's solutions create a
permanent document-based repository of historical health
information that is complementary and can be seamlessly integrated
with existing disparate clinical, financial and administrative
information systems, providing convenient electronic access to all
forms of patient information from any location, including secure
web-based access. For additional information, visit our website at
http://www.streamlinehealth.net/. "Safe Harbor" statement under the
Private Securities Litigation Reform Act of 1995 Statements made by
Streamline Health Solutions, Inc. that are not historical facts are
forward-looking statements that are subject to risks and
uncertainties. The forward-looking statements contained herein are
subject to certain risks, uncertainties and important factors that
could cause actual results to differ materially from those
reflected in the forward-looking statements, included herein. These
risks and uncertainties include, but are not limited to, the timing
of the closing of contracts and the timing of the subsequent
revenue recognition related thereto ,the impact of competitive
products and pricing, product demand and market acceptance, new
product development, key strategic alliances with vendors that
resell the Company products, the ability of the Company to control
costs, availability of products produced from third party vendors,
the healthcare regulatory environment, healthcare information
systems budgets, availability of healthcare information systems
trained personnel for implementation of new systems, as well as
maintenance of legacy systems, fluctuations in operating results
and other risks detailed from time to time in the Streamline Health
Solutions, Inc. filings with the U. S. Securities and Exchange
Commission. Readers are cautioned not to place undue reliance on
these forward-looking statements, which reflect management's
analysis only as of the date hereof. The Company undertakes no
obligation to publicly release the results of any revision to these
forward-looking statements, which may be made to reflect events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events. COMPANY CONTACT: INVESTOR CONTACT: J. Brian
Patsy Joe Diaz, Robert Blum, Joe Dorame Chief Executive Officer
Lytham Partners, LLC (513) 794-7100 (602) 889-9700 DATASOURCE:
Streamline Health Solutions, Inc. CONTACT: CONTACT: Company, J.
Brian Patsy, Chief Executive Officer, +1-513-794-7100, of
Streamline Health Solutions, Inc.; or Investors, Joe Diaz, Robert
Blum, or Joe Dorame, all of Lytham Partners, LLC, +1-602-889-9700,
for Streamline Health Solutions, Inc. Web Site:
http://www.streamlinehealth.net/
Copyright
Streamline Health Soluti... (NASDAQ:STRM)
Historical Stock Chart
From Jul 2024 to Aug 2024
Streamline Health Soluti... (NASDAQ:STRM)
Historical Stock Chart
From Aug 2023 to Aug 2024